These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of p16 and p14ARF in radio- and chemosensitivity of malignant gliomas. Simon M; Voss D; Park-Simon TW; Mahlberg R; Köster G Oncol Rep; 2006 Jul; 16(1):127-32. PubMed ID: 16786135 [TBL] [Abstract][Full Text] [Related]
8. Growth inhibitory effect on glioma cells of adenovirus-mediated p16/INK4a gene transfer in vitro and in vivo. Lee SH; Kim MS; Kwon HC; Park IC; Park MJ; Lee CT; Kim YW; Kim CM; Hong SI Int J Mol Med; 2000 Nov; 6(5):559-63. PubMed ID: 11029524 [TBL] [Abstract][Full Text] [Related]
9. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors. Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215 [TBL] [Abstract][Full Text] [Related]
10. Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene. Matsumura Y; Yamagishi N; Miyakoshi J; Imamura S; Takebe H Cancer Lett; 1997 May; 115(1):91-6. PubMed ID: 9097983 [TBL] [Abstract][Full Text] [Related]
11. Functional analysis of wild-type and malignant glioma derived CDKN2Abeta alleles: evidence for an RB-independent growth suppressive pathway. Arap W; Knudsen E; Sewell DA; Sidransky D; Wang JY; Huang HJ; Cavenee WK Oncogene; 1997 Oct; 15(17):2013-20. PubMed ID: 9366518 [TBL] [Abstract][Full Text] [Related]
12. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Sonoda Y; Yoshimoto T; Sekiya T Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535 [TBL] [Abstract][Full Text] [Related]
13. Growth arrest and suppression of tumorigenicity of bladder-carcinoma cell lines induced by the P16/CDKN2 (p16INK4A, MTS1) gene and other loci on human chromosome 9. Wu Q; Possati L; Montesi M; Gualandi F; Rimessi P; Morelli C; Trabanelli C; Barbanti-Brodano G Int J Cancer; 1996 Mar; 65(6):840-6. PubMed ID: 8631601 [TBL] [Abstract][Full Text] [Related]
14. Restoration of the p16 gene is related to increased radiosensitivity of p16-deficient lung adenocarcinoma cell lines. Fu XY; Zhang SW; Ran RQ; Shen ZH; Gu JX; Cao SL J Cancer Res Clin Oncol; 1998; 124(11):621-6. PubMed ID: 9860291 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Fueyo J; Gomez-Manzano C; Yung WK; Clayman GL; Liu TJ; Bruner J; Levin VA; Kyritsis AP Oncogene; 1996 Jan; 12(1):103-10. PubMed ID: 8552379 [TBL] [Abstract][Full Text] [Related]
16. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443 [TBL] [Abstract][Full Text] [Related]
17. Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma. Arap W; Knudsen ES; Wang JY; Cavenee WK; Huang HJ Oncogene; 1997 Feb; 14(5):603-9. PubMed ID: 9053859 [TBL] [Abstract][Full Text] [Related]
18. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas. Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344 [TBL] [Abstract][Full Text] [Related]
19. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Huang L; Goodrow TL; Zhang SY; Klein-Szanto AJ; Chang H; Ruggeri BA Cancer Res; 1996 Mar; 56(5):1137-41. PubMed ID: 8640773 [TBL] [Abstract][Full Text] [Related]
20. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas. Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]